EP 1378509 A4 20090325 - DRUGS CONTAINING TRIAZASPIRO 5.5 UNDECANE DERIVATIVES AS THE ACTIVE INGREDIENT
Title (en)
DRUGS CONTAINING TRIAZASPIRO 5.5 UNDECANE DERIVATIVES AS THE ACTIVE INGREDIENT
Title (de)
ARZNEIMITTEL MIT TRIAZASPIRO ç5.5]UNDECANDERIVATEN ALS WIRKSTOFF
Title (fr)
MEDICAMENTS CONTENANT COMME PRINCIPE ACTIF DES DERIVES DU TRIAZASPIRO 5.5 UNDECANE
Publication
Application
Priority
- JP 0202553 W 20020318
- JP 2001079611 A 20010319
Abstract (en)
[origin: EP1378509A1] A pharmaceutical composition for prevention and/or treatment for HIV infection or AIDS induced by the infection which comprises, as an active ingredient, a triazaspiroÄ5.5Üundecane derivative, a quaternary ammonium salt thereof, an N-oxide thereof, or a non-toxic salt thereof, and if necessary, it may be combined with at least one member of other agents for prevention and/or treatment for HIV infection (wherein all symbols are as defined in the specification.). <CHEM> The triazaspiroÄ5.5Üundecane derivatives, the quatemary ammonium salts thereof or the N-oxides thereof, or the non-toxic salts thereof are useful in preventing and/or treating HIV infection and AIDS induced by the infection.
IPC 8 full level
A61K 31/49 (2006.01); C07D 471/10 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); A61P 31/18 (2006.01); A61P 43/00 (2006.01); C07D 211/04 (2006.01); C07D 241/04 (2006.01)
CPC (source: EP KR US)
A61K 31/49 (2013.01 - EP US); A61K 31/499 (2013.01 - KR); A61K 31/5377 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61P 11/06 (2018.01 - EP); A61P 31/18 (2018.01 - EP); A61P 37/08 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07D 471/10 (2013.01 - EP US)
C-Set (source: EP US)
Citation (search report)
[E] EP 1378510 A1 20040107 - ONO PHARMACEUTICAL CO [JP]
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
EP 1378509 A1 20040107; EP 1378509 A4 20090325; BR 0208229 A 20040309; CA 2441162 A1 20020926; CN 1533390 A 20040929; CZ 20032532 A3 20040317; HU P0400241 A2 20040628; IL 157940 A0 20040328; JP WO2002074769 A1 20040708; KR 20030093248 A 20031206; MX PA03008528 A 20040630; NO 20034149 D0 20030917; NO 20034149 L 20031119; NZ 528270 A 20051028; PL 364469 A1 20041213; RU 2003128075 A 20050410; US 2004106619 A1 20040603; US 7285552 B2 20071023; WO 02074769 A1 20020926; ZA 200307318 B 20040729
DOCDB simple family (application)
EP 02705300 A 20020318; BR 0208229 A 20020318; CA 2441162 A 20020318; CN 02809833 A 20020318; CZ 20032532 A 20020318; HU P0400241 A 20020318; IL 15794002 A 20020318; JP 0202553 W 20020318; JP 2002573778 A 20020318; KR 20037012131 A 20030918; MX PA03008528 A 20020318; NO 20034149 A 20030917; NZ 52827002 A 20020318; PL 36446902 A 20020318; RU 2003128075 A 20020318; US 47262603 A 20030922; ZA 200307318 A 20030918